Successful Treatment of Methicillin-resistant Staphylococcus aureus Keratitis with Topical Ciprofloxacin
Ciprofloxacin is a new quinolone antibiotic with a broad spectrum of activity against most aerobic gram-positive and gram-negative bacteria. Topical ciprofloxacin (3 mg/ml) was used to treat bacterial keratitis caused by methicillin-resistant strains of Staphylococcus aureus in two patients. Both co...
Gespeichert in:
| Veröffentlicht in: | Ophthalmology (Rochester, Minn.) Minn.), 1991-11, Vol.98 (11), p.1690-1692 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1692 |
|---|---|
| container_issue | 11 |
| container_start_page | 1690 |
| container_title | Ophthalmology (Rochester, Minn.) |
| container_volume | 98 |
| creator | Insler, Michael S. Fish, Larry A. Silbernagel, Jeffrey Hobden, Jeffery A. O'Callaghan, Richard J. Hill, James M. |
| description | Ciprofloxacin is a new quinolone antibiotic with a broad spectrum of activity against most aerobic gram-positive and gram-negative bacteria. Topical ciprofloxacin (3 mg/ml) was used to treat bacterial keratitis caused by methicillin-resistant strains of Staphylococcus aureus in two patients. Both corneal ulcers had been previously treated with other antibiotics without success. Topical ciprofloxacin was curative in both cases. The authors recommend the use of topical ciprofloxacin for methicillin-resistant S. aureus keratitis. |
| doi_str_mv | 10.1016/S0161-6420(91)32067-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72703668</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161642091320670</els_id><sourcerecordid>72703668</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-604d01a062278773c7ffd3530270e309be1334396546186d3de9b066ec2c433a3</originalsourceid><addsrcrecordid>eNqFkE9v1DAQxS0EKtvCR6iUA0JwCB1nEic-IbTin1rUwy5nyzuZaI28yWI7hX57vN1VOfYyc3hv3sz8hLiU8EGCVFerXGSp6greafkeK1BtCc_EQja1LutW4nOxeLS8FOcx_gIApbA-E2eyA9AoF2K7mok4xmH2xTqwTTseUzENxQ9OW0fOezeWgaOLyWZhlex-e-8nmojmWNg5cG7XHGxyycXij0vbYj3tHVlfLN0-TIOf_lpy4yvxYrA-8utTvxA_v3xeL7-VN7dfvy8_3ZSEnU6lgroHaUFVVdu1LVI7DD02CFULjKA3LBFr1KqplexUjz3rTf6KqaIa0eKFeHvMzbt_zxyT2blI7L0deZqjaXMQKtVlY3M0UphiDDyYfXA7G-6NBHMgbB4ImwM-o6V5IGwgz12eFsybHff_p45Is_7mpNuYKQzBjuTio61BxEofYj4ebZxh3DkOJpLjkbh3gSmZfnJPHPIPpYaYRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72703668</pqid></control><display><type>article</type><title>Successful Treatment of Methicillin-resistant Staphylococcus aureus Keratitis with Topical Ciprofloxacin</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Insler, Michael S. ; Fish, Larry A. ; Silbernagel, Jeffrey ; Hobden, Jeffery A. ; O'Callaghan, Richard J. ; Hill, James M.</creator><creatorcontrib>Insler, Michael S. ; Fish, Larry A. ; Silbernagel, Jeffrey ; Hobden, Jeffery A. ; O'Callaghan, Richard J. ; Hill, James M.</creatorcontrib><description>Ciprofloxacin is a new quinolone antibiotic with a broad spectrum of activity against most aerobic gram-positive and gram-negative bacteria. Topical ciprofloxacin (3 mg/ml) was used to treat bacterial keratitis caused by methicillin-resistant strains of Staphylococcus aureus in two patients. Both corneal ulcers had been previously treated with other antibiotics without success. Topical ciprofloxacin was curative in both cases. The authors recommend the use of topical ciprofloxacin for methicillin-resistant S. aureus keratitis.</description><identifier>ISSN: 0161-6420</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/S0161-6420(91)32067-0</identifier><identifier>PMID: 1800931</identifier><identifier>CODEN: OPHTDG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Administration, Topical ; Aged ; Aged, 80 and over ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Ciprofloxacin - therapeutic use ; Corneal Ulcer - drug therapy ; Corneal Ulcer - microbiology ; Eye Infections, Bacterial - drug therapy ; Female ; Humans ; Male ; Medical sciences ; Methicillin Resistance ; Pharmacology. Drug treatments ; Staphylococcal Infections - drug therapy ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - isolation & purification ; Visual Acuity</subject><ispartof>Ophthalmology (Rochester, Minn.), 1991-11, Vol.98 (11), p.1690-1692</ispartof><rights>1991 American Academy of Ophthalmology, Inc</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-604d01a062278773c7ffd3530270e309be1334396546186d3de9b066ec2c433a3</citedby><cites>FETCH-LOGICAL-c389t-604d01a062278773c7ffd3530270e309be1334396546186d3de9b066ec2c433a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0161-6420(91)32067-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5333290$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1800931$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Insler, Michael S.</creatorcontrib><creatorcontrib>Fish, Larry A.</creatorcontrib><creatorcontrib>Silbernagel, Jeffrey</creatorcontrib><creatorcontrib>Hobden, Jeffery A.</creatorcontrib><creatorcontrib>O'Callaghan, Richard J.</creatorcontrib><creatorcontrib>Hill, James M.</creatorcontrib><title>Successful Treatment of Methicillin-resistant Staphylococcus aureus Keratitis with Topical Ciprofloxacin</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><description>Ciprofloxacin is a new quinolone antibiotic with a broad spectrum of activity against most aerobic gram-positive and gram-negative bacteria. Topical ciprofloxacin (3 mg/ml) was used to treat bacterial keratitis caused by methicillin-resistant strains of Staphylococcus aureus in two patients. Both corneal ulcers had been previously treated with other antibiotics without success. Topical ciprofloxacin was curative in both cases. The authors recommend the use of topical ciprofloxacin for methicillin-resistant S. aureus keratitis.</description><subject>Administration, Topical</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Corneal Ulcer - drug therapy</subject><subject>Corneal Ulcer - microbiology</subject><subject>Eye Infections, Bacterial - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methicillin Resistance</subject><subject>Pharmacology. Drug treatments</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - isolation & purification</subject><subject>Visual Acuity</subject><issn>0161-6420</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE9v1DAQxS0EKtvCR6iUA0JwCB1nEic-IbTin1rUwy5nyzuZaI28yWI7hX57vN1VOfYyc3hv3sz8hLiU8EGCVFerXGSp6greafkeK1BtCc_EQja1LutW4nOxeLS8FOcx_gIApbA-E2eyA9AoF2K7mok4xmH2xTqwTTseUzENxQ9OW0fOezeWgaOLyWZhlex-e-8nmojmWNg5cG7XHGxyycXij0vbYj3tHVlfLN0-TIOf_lpy4yvxYrA-8utTvxA_v3xeL7-VN7dfvy8_3ZSEnU6lgroHaUFVVdu1LVI7DD02CFULjKA3LBFr1KqplexUjz3rTf6KqaIa0eKFeHvMzbt_zxyT2blI7L0deZqjaXMQKtVlY3M0UphiDDyYfXA7G-6NBHMgbB4ImwM-o6V5IGwgz12eFsybHff_p45Is_7mpNuYKQzBjuTio61BxEofYj4ebZxh3DkOJpLjkbh3gSmZfnJPHPIPpYaYRA</recordid><startdate>19911101</startdate><enddate>19911101</enddate><creator>Insler, Michael S.</creator><creator>Fish, Larry A.</creator><creator>Silbernagel, Jeffrey</creator><creator>Hobden, Jeffery A.</creator><creator>O'Callaghan, Richard J.</creator><creator>Hill, James M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19911101</creationdate><title>Successful Treatment of Methicillin-resistant Staphylococcus aureus Keratitis with Topical Ciprofloxacin</title><author>Insler, Michael S. ; Fish, Larry A. ; Silbernagel, Jeffrey ; Hobden, Jeffery A. ; O'Callaghan, Richard J. ; Hill, James M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-604d01a062278773c7ffd3530270e309be1334396546186d3de9b066ec2c433a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Administration, Topical</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Corneal Ulcer - drug therapy</topic><topic>Corneal Ulcer - microbiology</topic><topic>Eye Infections, Bacterial - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methicillin Resistance</topic><topic>Pharmacology. Drug treatments</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - isolation & purification</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Insler, Michael S.</creatorcontrib><creatorcontrib>Fish, Larry A.</creatorcontrib><creatorcontrib>Silbernagel, Jeffrey</creatorcontrib><creatorcontrib>Hobden, Jeffery A.</creatorcontrib><creatorcontrib>O'Callaghan, Richard J.</creatorcontrib><creatorcontrib>Hill, James M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Insler, Michael S.</au><au>Fish, Larry A.</au><au>Silbernagel, Jeffrey</au><au>Hobden, Jeffery A.</au><au>O'Callaghan, Richard J.</au><au>Hill, James M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful Treatment of Methicillin-resistant Staphylococcus aureus Keratitis with Topical Ciprofloxacin</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>1991-11-01</date><risdate>1991</risdate><volume>98</volume><issue>11</issue><spage>1690</spage><epage>1692</epage><pages>1690-1692</pages><issn>0161-6420</issn><eissn>1549-4713</eissn><coden>OPHTDG</coden><abstract>Ciprofloxacin is a new quinolone antibiotic with a broad spectrum of activity against most aerobic gram-positive and gram-negative bacteria. Topical ciprofloxacin (3 mg/ml) was used to treat bacterial keratitis caused by methicillin-resistant strains of Staphylococcus aureus in two patients. Both corneal ulcers had been previously treated with other antibiotics without success. Topical ciprofloxacin was curative in both cases. The authors recommend the use of topical ciprofloxacin for methicillin-resistant S. aureus keratitis.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>1800931</pmid><doi>10.1016/S0161-6420(91)32067-0</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0161-6420 |
| ispartof | Ophthalmology (Rochester, Minn.), 1991-11, Vol.98 (11), p.1690-1692 |
| issn | 0161-6420 1549-4713 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72703668 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Administration, Topical Aged Aged, 80 and over Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Ciprofloxacin - therapeutic use Corneal Ulcer - drug therapy Corneal Ulcer - microbiology Eye Infections, Bacterial - drug therapy Female Humans Male Medical sciences Methicillin Resistance Pharmacology. Drug treatments Staphylococcal Infections - drug therapy Staphylococcus aureus - drug effects Staphylococcus aureus - isolation & purification Visual Acuity |
| title | Successful Treatment of Methicillin-resistant Staphylococcus aureus Keratitis with Topical Ciprofloxacin |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T13%3A39%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20Treatment%20of%20Methicillin-resistant%20Staphylococcus%20aureus%20Keratitis%20with%20Topical%20Ciprofloxacin&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=Insler,%20Michael%20S.&rft.date=1991-11-01&rft.volume=98&rft.issue=11&rft.spage=1690&rft.epage=1692&rft.pages=1690-1692&rft.issn=0161-6420&rft.eissn=1549-4713&rft.coden=OPHTDG&rft_id=info:doi/10.1016/S0161-6420(91)32067-0&rft_dat=%3Cproquest_cross%3E72703668%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72703668&rft_id=info:pmid/1800931&rft_els_id=S0161642091320670&rfr_iscdi=true |